Doubled Chromosome Heart Cells Beat Stronger in Lab Tests

Doubled Chromosome Heart Cells grown in a laboratory beat more strongly and more quickly than conventional lab-grown heart muscle, according to researchers in Japan, offering a fresh route toward tissue that behaves more like an adult heart. The team fused stem cells before turning them into heart muscle, copying a chromosome-doubling step that happens naturally as heart cells mature inside the body. That simple change in order, the researchers say, produced cells that were larger, carried more energy-producing structures, and showed a more adult pattern of gene activity.

Heart muscle grown from stem cells has long frustrated scientists because it tends to stay young. In the laboratory, such cells often resemble early-stage tissue rather than the sturdy muscle that must contract reliably for a lifetime. That gap matters for medicine: immature cells are less useful for testing new drugs, for modelling disease, and for any future transplant treatment for heart failure. The new work tackles the gap directly by asking what maturation itself does, and then rebuilding that step in the dish.

Why lab-grown heart tissue stays young

Most cells in the body carry two sets of chromosomes, one inherited from each parent. Heart muscle is an exception. As these cells mature, many of them double their chromosome sets, ending up with four sets instead of two. The study, published in Communications Biology in August 2026, notes that this doubling is part of the normal path from a dividing, early-stage cell to a settled, working adult cell. Conventional laboratory methods skip it, leaving most lab-grown heart cells stuck with the younger chromosome count.

Doubled Chromosome Heart Cells were designed to close that gap. Researchers at the Tokyo Metropolitan Institute of Medical Science first fused stem cells together so that each fused cell carried the doubled set, then coaxed those fused cells to become heart muscle. The fused cells stayed stable, kept their ability to become other cell types, and grew into heart muscle that was visibly larger than muscle made the usual way. Size alone is not proof of maturity, the team notes, but it matches what happens inside the body, where heart cells grow as they settle into adult work.

Gene readings strengthened the case. When the team compared the two kinds of lab-grown muscle, the doubled-chromosome version switched off many genes linked to cell division, a change that mirrors the way adult heart cells stop dividing and focus on contraction. At the same time, the cells increased both the amount and the working capacity of their mitochondria, the structures that supply the energy every heartbeat demands. Together, those shifts paint a picture of tissue moving closer to its adult state, rather than simply growing bigger in the dish.

Fusing cells first, then growing heart muscle

The order of operations is the heart of the method. Earlier approaches tried to double chromosomes after heart muscle had already formed, and that direct route did not work well. The team therefore reversed the sequence: fuse first, differentiate second. To fuse the stem cells, they used particles from a virus long used in laboratory cell-fusion work, a tool chosen because it reliably joins cells without adding new genetic instructions of its own.

Electrical measurements then tested whether the change mattered for function, not just appearance. As lab-grown heart cells beat on a culture plate, their shifting inner structures change the electrical resistance across the plate, and that signal can be tracked over time. In those traces, the doubled-chromosome muscle reached higher peaks and climbed to them faster than the conventional version. Strong and fast contraction is a hallmark of mature heart muscle, and the researchers present the faster, stronger beats as the clearest functional sign that their approach worked.

That result also explains why the method may travel beyond heart research. Several other cell types double their chromosome sets as they mature, including liver cells, skeletal muscle cells, and the cells that make platelets. If the same fuse-first sequence works for them, laboratories could build more faithful models for a wider range of tissues. For now, the heart result is the proof of principle, and the team is careful to present it as laboratory progress rather than a treatment ready for patients.

What stronger beating could mean for patients

For people living with heart failure, the promise is easy to state and hard to deliver: replacement muscle that actually behaves like adult tissue. Transplant trials using lab-grown heart cells are already under way in some centres, and more mature cells could make those efforts safer and more effective, because adult-like cells are less likely to behave unpredictably once implanted. Drug testing could benefit sooner, since a more adult model should give a truer read on whether a candidate medicine helps or harms beating tissue.

Doubled Chromosome Heart Cells will still need long safety and durability testing before anyone talks about clinics. The researchers have shown stronger, faster beating in the laboratory, not restored pumping in a patient, and the path from a culture plate to a transplant is measured in years of animal work, manufacturing checks, and regulated trials. Readers should therefore treat this as a meaningful step in how scientists build heart tissue, not as a cure arriving this year. The value lies in the method: by copying a natural maturation step, the team has given researchers a better tool for studying disease, screening medicines, and, eventually, designing replacement tissue.

Related coverage on this site includes a recent look at how a slow response to a farm outbreak raised health alarms and a profile of a physicist honoured for work on the unity of forces. The heart-cell findings were reported by MedicalXpress, drawing on the Tokyo research team.